PLX7904
PLX7904 (PB04) is a selective paradox-breaker RAF inhibitor that suppresses ERK1/2 signaling in BRAF-mutant melanoma cells without inducing paradoxical activation in RAS-mutant contexts. Its profile supports its use in vitro and in vivo for investigating targeted therapies in oncology, particularly for overcoming resistance mechanisms in MAPK pathway-driven cancers.
Product Specifications
CAS Number
1393465-84-3
Product Name Alternative
B-Raf (V600E), Inhibitor, inhibit, PB 04, PB04, PB-04, PLX7904, PLX-7904, PLX 7904, Raf, Raf kinases
Field of Research
Signal Transduction
Purity
96.27% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (7.8 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:100 mg/mL (195.11 mM) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble)
Smiles
CCN (C) S (=O) (=O) Nc1ccc (F) c (C (=O) c2c[nH]c3ncc (cc23) -c2cnc (nc2) C2CC2) c1F
Molecular Formula
C24H22F2N6O3S
Molecular Weight
512.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2046403-01 0.1 mL
APC-Linked Polyclonal Antibody to Delta-Sleep Inducing Peptide (dSIP)
Sign In for Pricing
View Details